About Kerafast
Kerafast is a Healthcare company based in Boston (United States) founded in 2010, and was acquired by LSBio in December 2020. Bioreagents and research materials are supplied for life science research. Kerafast has raised $500 thousand across 3 funding rounds from investors including LSBio and FCA Venture Partners. Its website kerafast.com draws about 28 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its competitors include Teknova, Meridian Bioscience and BioChain; 1 of its 3 listed competitors has raised funding.
Company details
Kerafast was founded in 2010 in Boston, United States, and operates in the life sciences sector. Bioreagents and research materials are developed and marketed to support life science companies. Products include antibodies, cell culture and transfection reagents, DNA vectors and clones, purified nucleic acids, proteins, enzymes, peptides, virus vectors, buffers, chemicals, microarray slides, and plasticware. Services for life science research are also provided.
- Headquarters Boston, United States
- Stage Acquired
- SectorsHealthcare
- Website kerafast.com
- Social LinkedIn X Facebook
- Acquired by LSBio (Dec 2020)
Funding Insights of Kerafast
Kerafast has successfully raised a total of $500K across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $250 thousand completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $500,000
- Total Rounds 3
- Last Round Debt – Conventional — $250,000
- First Round $500,000
(Mar 2012)
- Investors Count 1
All 3 funding rounds of Kerafast with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2016 | $250,000 | Debt – Conventional | – | – | – |
| Mar 2015 | $634,801 | Debt – Conventional | – | – | – |
| Mar 2012 | $500,000 | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Kerafast
Kerafast has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include LSBio and FCA Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Offline-focused VC firm investing primarily in the US | fcavp.com | Brentwood, United States | ||
Reagents and kits for immunology research are developed and manufactured. | 1995 | lsbio.com | Seattle, United States |
Investor details for Kerafast
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Kerafast
10 people are tracked at Kerafast (1 in leadership, 1 in board & advisors, 8 in team).
| Name | Role | Group |
|---|---|---|
Michael Fiebig | Chief Scientific Officer | Leadership |
Nicholas Hutchings | Advisor | Board & advisors |
MILI KHATARKAR | Scientist I R&d | Team |
Rachel Gibson | Scientist - Upstream Supervisor | Team |
Adriana Correa | Business Development Manager | Team |
Alex Scott | Business Development Manager UK And EU | Team |
Kathrin Günther | Business Development Manager Europe | Team |
Cameron Barker | Scientist II | Team |
Daniel S. | Scientist | Team |
Sarah Teaz | Scientist II | Team |
Complete people profiles for Kerafast
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Kerafast
4 dated milestones of Kerafast across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Kerafast is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Debt – Conventional, of $250K.
- Exit Acquired by LSBio.
Competitors of Kerafast
Kerafast has 3 listed competitors in our database, 1 of them funded. They include Teknova, Meridian Bioscience and BioChain.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| teknova.com | 1996 | Hollister, United States | 290 | Molecular biology reagents and kits are supplied for research applications. | ||
| meridianbioscience.com | 1976 | Ohio, United States | Molecular diagnostic device and kits | |||
| biochain.com | 1994 | Hayward, United States | $7.34M | 24 | Provider of products and services for clinical diagnosis, genomics, and proteomics |
Detailed competitors of Kerafast
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Kerafast
The website of Kerafast (kerafast.com) receives about 27.6K visits a month.
- Monthly visits27.6K
▲ 27.3% vs previous month
Websites whose visitors overlap most with Kerafast. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ginkgobioworks.com | 100% | 10.8K | #2,283,405 | View details | |
technical.sanguinebio.com | technical.sanguinebio.com | 86% | – | ||
| absoluteantibody.com | 85% | 34.2K | #944,741 | View details | |
ion.ac.cn | ion.ac.cn | 80% | #2,764,166 | – | |
| bioivt.com | 80% | 78.2K | #447,808 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Kerafast
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Kerafast (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kerafast
Complete news archive for Kerafast
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kerafast
Kerafast was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Kerafast is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Kerafast is a funded company, having raised a total of $500K across 3 funding rounds to date. The company's 1st funding round was a Series A of $500K, raised on Mar 2012.
Kerafast was founded in 2010 in Boston, United States, and operates in the life sciences sector. Bioreagents and research materials are developed and marketed to support life science companies. Products include antibodies, cell culture and transfection reagents, DNA vectors and clones, purified nucleic acids, proteins, enzymes, peptides, virus vectors, buffers, chemicals, microarray slides, and plasticware. Services for life science research are also provided.
Kerafast's top competitors include Meridian Bioscience, Teknova and BioChain.
Kerafast has 2 investors. Key investors include LSBio, and FCA Venture Partners.
Yes. Kerafast was acquired by LSBio in December 2020.